Milestone Pharmaceuticals Inc. (MIST) income statement
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.37−0.03 (-7.06%)
Close on Nov 20, 2026Market cap $46.20MP/E –Yield –
Milestone Pharmaceuticals Inc. financial ratios
See a number that looks wrong?